Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
43.69
-0.65 (-1.47%)
At close: Nov 16, 2026, 4:00 PM EST
43.45
-0.24 (-0.56%)
Pre-market: Nov 17, 2026, 4:00 AM EST

Boston Scientific Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
21,07020,07416,74714,24012,68211,888
Revenue Growth
8.89%19.87%17.61%12.29%6.68%19.92%
Gross Profit
14,32313,80711,4579,8498,6798,128
Operating Income
4,1383,9713,0022,4172,0331,824
Net Income
3,5022,8981,8531,570642985
Earnings Per Share
2.371.941.251.070.450.69
EPS Growth
26.63%55.20%16.82%138.42%-34.96%-

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
MedSurg
7,0616,8245,9935,4224,9114,633
Cardiovascular
14,01013,25010,7558,8197,8317,242
Revenue (Total)
21,06920,07416,74714,24012,68211,888

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6091,9654148659281,925
Total Debt
11,95311,97211,2289,5689,3439,525
Net Cash (Debt)
-11,344-10,007-10,814-8,703-8,415-7,600
Net Cash Growth
------
Net Cash Per Share
-7.67-6.70-7.28-5.95-5.84-5.30

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
4,2344,5343,4352,5031,5261,870
Capital Expenditures
-903-876-790-711-588-554
Free Cash Flow
3,3313,6582,6451,7929381,316
Free Cash Flow Growth
-12.89%38.30%47.60%91.05%-28.72%16.25%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
67.98%68.78%68.41%69.16%68.44%68.37%
Operating Margin
19.64%19.78%17.93%16.97%16.03%15.34%
Pretax Margin
17.35%16.86%13.62%13.94%9.00%9.06%
Profit Margin
16.62%14.44%11.06%11.03%5.06%8.29%
FCF Margin
15.81%18.22%15.79%12.58%7.40%11.07%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
18.4548.7871.0453.94103.2361.46
Forward PE
14.1828.7133.0826.7624.5123.73
P/FCF Ratio
19.0138.6449.7747.2670.6546.00
PS Ratio
3.017.047.865.955.235.09